NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

OPYL LIMITED (OPL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
OPYL LIMITED11/12/2019
SHAREROOT LTD21/12/201511/12/2019
MONTO MINERALS LTD21/02/200321/12/2015
MONTO MINERALS NL21/02/2003

Shareholder links

Our website ranking of OPL: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000070856
Address: 105 Wellington Street St Kilda, VIC
Tel:  + 61 3 9923 1222Fax: + 61 3 9923 1222

Date first listed: 07/03/1996
Company Secretary: David Lilja
Sector: Software & Services Industry Group: XMJ
Activities: Ownership and operation of a user-generated content marketing platform

News & Events

Expand this box to read and print

The suspension of trading in the securities of Opyl Limited will be lifted immediately following the release of an announcement by OPL regarding an entitlement offer.

12/12/2023

The company releases a Cleansing Notice regarding the entitlement offer.

12/12/2023

The company releases a notice of proposed issue of securities.

12/12/2023

Opyl has successfully completed a $576,000 placement at an offer price of $0.03 per share from professional and sophisticated investors. A 2 for 5 non-renounceable rights issue offer at $0.03 per share is also being offered to eligible shareholders to raise up to $1.43m. Opyl has secured advanced commitments for $635,000 in a combination of rights acceptances in advance and shortfall commitments prior to the Entitlement Offering opening date. Proceeds from both the placement and rights issue will be used to progress the commercialisation of Opyl's recently launched predictive analytics and clinical trial insights platform, TrialKey.

12/12/2023

The securities of Opyl Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of OPL, pending the release of an announcement regarding an entitlement offer.

12/12/2023

The suspension of trading in the securities of Opyl Limited will be lifted immediately following the release by OPL of an announcement regarding a capital raise.

23/12/2022

The company releases a Rights Issue Offer Booklet.

23/12/2022

The company announces a non-renounceable rights issue, to raise up to $480,390. The funds raised from the placement and rights issue will be applied to: accelerating the conversion of the sales pipeline, development and release of additional functionality on Opin that provides for greater automation connecting patients to trial sites, supporting scale and additional income stream, expansion of Opin into key APAC markets (NZ, Korea and Taiwan) and first entry into US markets, ongoing product development and enhancement, working capital.

23/12/2022

The company releases a letter to its ineligible shareholders regarding the rights issue.

23/12/2022

The company releases a cleansing notice in relation to its nonrenounceable rights issue offer to eligible shareholders.

23/12/2022

The company makes a clarification on its announcement. The company wants to correct this statement: "The Placement Shares are intended to be issued under the Company's current capacity pursuant to ASX Listing Rule 7.1(8,157,808 Shares) and 7.1A (5,438,538 Shares)." This should state: The Placement Shares are intended to be issued under the Company's current, capacity pursuant to ASX Listing Rule 7.1(8,157,808 Shares) and 7.1A (1,508,859 Shares).

23/12/2022

The company releases a notice of proposed issue of securities.

23/12/2022

Opyl has successfully received commitments from institutional and sophisticated investors for approximately $290,000 at $0.03 via a placement. A 1 for 4 non-renounceable rights issue offer at $0.03 per share is being offered to eligible shareholders to raise up to A$480,390. A top-up facility will be offered, under which eligible shareholders can apply to take up new shares in excess of their pro-rata entitlement. Proceeds from the raises will be used to extend Opin's market share in APAC, accelerate conversion of the sales pipeline, open new functionality in Opin, ongoing product development and enhancement and improve working capital.

23/12/2022

The securities of Opyl Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of OPL, pending the release of an announcement regarding a capital raise

23/12/2022

The suspension of trading in the securities of Opyl Limited will be lifted immediately following the release by OPL of an announcement regarding the Company's announcement dated 3 September 2020.

07/09/2020

The company provides additional information in relation to its announcement on 3 September 2020. The cost of the product to date has been circa $800k. The software is now functional however the company will continue to further improve and refine the software with future upgrades and expansion of features, which is anticipated to cost up to another $500K in development. The company will continue to develop its marketing, sales and ongoing customer service support expenditure forecast models as well as revenue models and provides shareholders and the market with updates. The company is currently finalising its R&D application for the 2020 financial year.

07/09/2020

The securities of Opyl Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of OPL, pending the release of an announcement.

04/09/2020

In reference to the two new contracts, individually, these do not represent a material event as they will not increase the company's forecast revenue by greater than 10% for the year ended 30 June 2020. The intention of the company's announcement on 20 May 2020 is to provide shareholders regular and ongoing overview in respect of its progress. Additional information in relation to these contracts have been provided.

25/05/2020

The suspension of trading in the securities of Opyl Limited ("˜OPL') will be lifted from the commencement of trading on Tuesday, 26 May 2020, following the release by OPL of an announcement regarding the two new contracts announced on Wednesday 20 May 2020.

25/05/2020

The securities of Opyl Limited will be suspended from quotation from the commencement of trading on Friday 22 May 2020 under Listing Rule 17.2, at the request of OPL, pending the release of an announcement regarding the two new contracts announced on Wednesday 20 May 2020.

22/05/2020

name changed from ShareRoot Ltd

11/12/2019

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    10/03/2022Julian Chick138,088$0.075$10,357
    09/02/2022Mark Ziirsen67,500$0.096$6,480
    24/01/2022Megan Robertson46,901$0.115$5,394
    30/11/2021Julian Chick100,000$0.110$11,000
    25/11/2021Damon Rasheed70,000$0.115$8,050

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Mark ZiirsenNon Exec Chairman21/09/2020
    Saurabh JainInterim CEO24/11/2023
    Misha McPhersonCOO02/03/2016
    Mark SimariNon Exec Director04/09/2023
    Antanas GuogaNon Exec Director04/09/2023
    Damon RasheedExecutive Director01/02/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Megan RobertsonNon Exec Director05/05/202104/09/2023
    Michelle GallaherCEO14/03/201905/07/2023
    Julian ChickChairman06/05/201914/02/2023
    Marat BasyrovNon Exec Director01/03/201918/11/2021
    Andrew BursillCFO12/01/201624/05/2019
    Harvey KaplanNon Exec Director01/02/201906/05/2019
    Noah Abelson-GertlerExecutive Director12/01/201601/03/2019
    Lee RodneNon Exec Chairman26/04/201701/02/2019
    Peter McLennanNon Exec Director31/07/201701/02/2019
    James AllchurchManaging Director, CEO09/12/200901/09/2016
    Gary SteinepreisDirector26/06/200912/01/2016
    Patrick BurkeDirector26/06/200912/01/2016

    Date of first appointment, title may have changed.